Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
15.80
-0.65 (-3.95%)
May 12, 2026, 3:11 PM CST

SHE:300122 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,7092,6262,7066,3412,6224,308
Trading Asset Securities
--11.53---
Cash & Short-Term Investments
1,7092,6262,7176,3412,6224,308
Cash Growth
-44.30%-3.37%-57.15%141.81%-39.13%199.68%
Accounts Receivable
10,92511,16516,30227,05920,61412,868
Other Receivables
64.47148.1210.977.88.396.87
Receivables
10,98911,31316,31327,06620,62212,874
Inventory
3,5735,00322,2448,9868,0207,385
Prepaid Expenses
-0.144.919.73-0.59
Other Current Assets
145.8977.16124.31111.37148.53185.63
Total Current Assets
16,41819,01941,40342,51431,41324,754
Property, Plant & Equipment
5,7645,8806,1655,1204,6933,557
Long-Term Investments
289.35289.35295295284.5239
Goodwill
19.2819.2819.2819.2819.2819.28
Other Intangible Assets
561.56574.48346.25317.68352.71342.8
Long-Term Deferred Tax Assets
3,7483,697966.88569.19186.08115.34
Long-Term Deferred Charges
2,1372,0901,8711,088731.97485.04
Other Long-Term Assets
154.96150.07231.11308.42322.5534.91
Total Assets
29,09231,72051,29750,23238,00430,047
Accounts Payable
439.221,2415,82313,1429,8079,178
Accrued Expenses
27.71578.71522.161,6731,2401,090
Short-Term Debt
560.048,59411,9022,6351,785568.86
Current Portion of Long-Term Debt
2,878765.6285.0136.41--
Current Portion of Leases
-9.211.7710.29.810.25
Current Income Taxes Payable
20.096.5386.86434.59347.7933.25
Current Unearned Revenue
58.9483.411.8711.31--
Other Current Liabilities
1,2441,125418.82143.8640.1799.62
Total Current Liabilities
5,22812,40418,86118,08613,23011,871
Long-Term Debt
7,8582,9091,242328.08210.64236.41
Long-Term Leases
7.849.5416.6725.3127.7612.24
Long-Term Unearned Revenue
250.08256.05281.68228.27238.34222.2
Long-Term Deferred Tax Liabilities
35.6635.6644.3157.9660.7748.34
Total Liabilities
13,38015,61420,44618,72613,76812,390
Common Stock
2,3942,3942,3942,4001,6001,600
Additional Paid-In Capital
210.19210.19197.8847.96207.96207.96
Retained Earnings
12,84713,23628,26229,05822,42815,849
Total Common Equity
15,45115,84030,85431,50624,23617,657
Minority Interest
260.97266.35-2.23---
Shareholders' Equity
15,71216,10630,85131,50624,23617,657
Total Liabilities & Equity
29,09231,72051,29750,23238,00430,047
Total Debt
11,30412,28713,2573,0352,033817.76
Net Cash (Debt)
-9,595-9,662-10,5403,305588.943,490
Net Cash Growth
---461.19%-83.13%-
Net Cash Per Share
-4.01-4.04-4.401.380.251.45
Filing Date Shares Outstanding
2,3942,3942,3942,4002,4002,400
Total Common Shares Outstanding
2,3942,3942,3942,4002,4002,400
Working Capital
11,1906,61522,54224,42818,18312,883
Book Value Per Share
6.456.6212.8913.1310.107.36
Tangible Book Value
14,87115,24630,48831,16923,86417,295
Tangible Book Value Per Share
6.216.3712.7412.999.947.21
Buildings
-2,8802,8402,5221,7051,042
Machinery
-3,6053,3962,5262,0641,369
Construction In Progress
-1,5471,5851,2871,8361,825
Source: S&P Global Market Intelligence. Standard template. Financial Sources.